Gene · 4607
Papers3,985
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 3,985
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ca2+ attenuates nucleation activity of leiomodin. | Protein Sci | 2022 | 35762710 | PubTator, text mining | PubMed |
| Clinical exome sequencing of 1000 families with complex immune phenotypes: Toward comprehensive genomic evaluations. | J Allergy Clin Immunol | 2022 | 35753512 | PubTator, text mining | PubMed |
| Transcriptome analysis uncovers the autophagy-mediated regulatory patterns of the immune microenvironment in dilated cardiomyopathy. | J Cell Mol Med | 2022 | 35752958 | PubTator, text mining | PubMed |
| Cholesterol and matrisome pathways dysregulated in astrocytes and microglia. | Cell | 2022 | 35750033 | PubTator, text mining | PubMed |
| Clinical characteristics and survival of children with hypertrophic cardiomyopathy in China: A multicentre retrospective cohort study. | EClinicalMedicine | 2022 | 35747179 | PubTator, text mining | PubMed |
| Editorial to the Special Issue "Molecular Motors: From Single Molecules to Cooperative and Regulatory Mechanisms In Vivo". | Int J Mol Sci | 2022 | 35743049 | PubTator, text mining | PubMed |
| Exploring the Potential of Symmetric Exon Deletion to Treat Non-Ischemic Dilated Cardiomyopathy by Removing Frameshift Mutations in TTN. | Genes (Basel) | 2022 | 35741855 | PubTator, text mining | PubMed |
| Oxidative Stress Parameters as Biomarkers of Cardiovascular Disease towards the Development and Progression. | Antioxidants (Basel) | 2022 | 35740071 | PubTator, text mining | PubMed |
| A Comprehensive Outlook on Dilated Cardiomyopathy (DCM): State-Of-The-Art Developments with Special Emphasis on OMICS-Based Approaches. | J Cardiovasc Dev Dis | 2022 | 35735803 | PubTator, text mining | PubMed |
| Contemporary Diagnosis and Management of Hypertrophic Cardiomyopathy: The Role of Echocardiography and Multimodality Imaging. | J Cardiovasc Dev Dis | 2022 | 35735798 | PubTator, text mining | PubMed |
| A Novel In Silico Electromechanical Model of Human Ventricular Cardiomyocyte. | Front Physiol | 2022 | 35721558 | PubTator, text mining | PubMed |
| MicroRNA expression profiles in familial hypertrophic cardiomyopathy with myosin-binding protein C3 (MYBPC3) gene mutations. | BMC Cardiovasc Disord | 2022 | 35717150 | PubTator, text mining | PubMed |
| Frequency, Penetrance, and Variable Expressivity of Dilated Cardiomyopathy-Associated Putative Pathogenic Gene Variants in UK Biobank Participants. | Circulation | 2022 | 35708014 | PubTator, text mining | PubMed |
| Pharmacological Management of Hypertrophic Cardiomyopathy: From Bench to Bedside. | Drugs | 2022 | 35696053 | PubTator, text mining | PubMed |
| Right ventricular function declines prior to left ventricular ejection fraction in hypertrophic cardiomyopathy. | J Cardiovasc Magn Reson | 2022 | 35692049 | PubTator, text mining | PubMed |
| Spatial region-resolved proteome map reveals mechanism of COVID-19-associated heart injury. | Cell Rep | 2022 | 35679865 | PubTator, text mining | PubMed |
| CRISPR Modeling and Correction of Cardiovascular Disease. | Circ Res | 2022 | 35679361 | PubTator, text mining | PubMed |
| Contemporary family screening in hypertrophic cardiomyopathy: the role of cardiovascular magnetic resonance. | Eur Heart J Cardiovasc Imaging | 2022 | 35670722 | PubTator, text mining | PubMed |
| Modeling hypertrophic cardiomyopathy with human cardiomyocytes derived from induced pluripotent stem cells. | Stem Cell Res Ther | 2022 | 35659761 | PubTator, text mining | PubMed |
| A genetic correlation scan identifies blood proteins associated with bone mineral density. | BMC Musculoskelet Disord | 2022 | 35659283 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4607/papers?page=44